Mauremys reevesii isolate NIE-2019 linkage group 26, ASM1616193v1, whole genome shotgun sequence.
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Archelosauria; Testudinata; Testudines; Cryptodira; Durocryptodira; Testudinoidea; Geoemydidae; Geoemydinae; Mauremys.
REFSEQ INFORMATION: The reference sequence is identical to\nCM028001.1.\nAssembly name: ASM1616193v1\nThe genomic sequence for this RefSeq record is from the\nwhole-genome assembly released by the Anhui normal university on\n2020/12/22. The original whole-genome shotgun project has the\naccession JADWOL000000000.1.\n\n##Genome-Assembly-Data-START##\nAssembly Provider :: Anhui normal university\nAssembly Date :: MAY-2019\nAssembly Method :: NextDenovo v. 2.0-beta.1\nGenome Representation :: Full\nExpected Final Version :: Yes\nGenome Coverage :: 96.7x\nSequencing Technology :: Oxford Nanopore; Illumina\n##Genome-Assembly-Data-END##\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: NCBI\nAnnotation Status :: Full annotation\nAnnotation Name :: Mauremys reevesii Annotation Release\n 100\nAnnotation Version :: 100\nAnnotation Pipeline :: NCBI eukaryotic genome annotation\n pipeline\nAnnotation Software Version :: 8.5\nAnnotation Method :: Best-placed RefSeq; Gnomon\nFeatures Annotated :: Gene; mRNA; CDS; ncRNA\n##Genome-Annotation-Data-END##
Derived by automated computational analysis using gene prediction method: Gnomon.
uncharacterized LOC120391741, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized LOC120391741, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
uncharacterized LOC120391741, transcript variant X2
uncharacterized LOC120391741, transcript variant X5
uncharacterized LOC120391741, transcript variant X3
uncharacterized LOC120391741, transcript variant X1
uncharacterized LOC120391741, transcript variant X8
uncharacterized LOC120391741, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
uncharacterized LOC120391742, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized LOC120391742, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 116 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 30 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
calcium and integrin binding family member 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
calcium and integrin binding family member 3, transcript variant X4
calcium and integrin binding family member 3, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
calcium and integrin binding family member 3, transcript variant X1
calcium and integrin binding family member 3, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
calcium and integrin binding family member 3, transcript variant X3
calcium and integrin-binding family member 3 isoform X3
calcium and integrin-binding family member 3 isoform X2
calcium and integrin-binding family member 3 isoform X1
family with sequence similarity 32 member A
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
adaptor related protein complex 1 subunit mu 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
adaptor related protein complex 1 subunit mu 1, transcript variant X1
adaptor related protein complex 1 subunit mu 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
epidermal growth factor receptor pathway substrate 15 like 1, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
epidermal growth factor receptor pathway substrate 15 like 1, transcript variant X7
epidermal growth factor receptor substrate 15-like 1 isoform X7
epidermal growth factor receptor substrate 15-like 1 isoform X5
epidermal growth factor receptor pathway substrate 15 like 1, transcript variant X11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
epidermal growth factor receptor substrate 15-like 1 isoform X10
epidermal growth factor receptor pathway substrate 15 like 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
epidermal growth factor receptor pathway substrate 15 like 1, transcript variant X6
epidermal growth factor receptor pathway substrate 15 like 1, transcript variant X4
epidermal growth factor receptor pathway substrate 15 like 1, transcript variant X1
epidermal growth factor receptor pathway substrate 15 like 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
epidermal growth factor receptor pathway substrate 15 like 1, transcript variant X10
epidermal growth factor receptor pathway substrate 15 like 1, transcript variant X9
epidermal growth factor receptor substrate 15-like 1 isoform X6
epidermal growth factor receptor substrate 15-like 1 isoform X3
epidermal growth factor receptor substrate 15-like 1 isoform X4
epidermal growth factor receptor substrate 15-like 1 isoform X2
epidermal growth factor receptor substrate 15-like 1 isoform X1
epidermal growth factor receptor substrate 15-like 1 isoform X9
epidermal growth factor receptor pathway substrate 15 like 1, transcript variant X8
epidermal growth factor receptor substrate 15-like 1 isoform X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 38 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
chromosome 26 C19orf44 homolog, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
chromosome 26 C19orf44 homolog, transcript variant X3
chromosome 26 C19orf44 homolog, transcript variant X1
uncharacterized protein C19orf44 homolog isoform X1
uncharacterized protein C19orf44 homolog isoform X2
calcium homeostasis endoplasmic reticulum protein, transcript variant X3
calcium homeostasis endoplasmic reticulum protein, transcript variant X1
calcium homeostasis endoplasmic reticulum protein isoform X3
calcium homeostasis endoplasmic reticulum protein isoform X1
calcium homeostasis endoplasmic reticulum protein, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
calcium homeostasis endoplasmic reticulum protein isoform X2
uncharacterized LOC120391618, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
uncharacterized LOC120391618, transcript variant X1
mediator complex subunit 26, transcript variant X4
mediator complex subunit 26, transcript variant X3
mediator complex subunit 26, transcript variant X2
mediator complex subunit 26, transcript variant X1
mediator complex subunit 26, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
mediator complex subunit 26, transcript variant X9
mediator complex subunit 26, transcript variant X7
mediator complex subunit 26, transcript variant X8
mediator complex subunit 26, transcript variant X6
mediator complex subunit 26, transcript variant X10
mediator of RNA polymerase II transcription subunit 26 isoform X2
mediator of RNA polymerase II transcription subunit 26 isoform X3
mediator of RNA polymerase II transcription subunit 26 isoform X1
mediator of RNA polymerase II transcription subunit 26 isoform X4
transmembrane protein 38A, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
trimeric intracellular cation channel type A isoform X1
transmembrane protein 38A, transcript variant X4
transmembrane protein 38A, transcript variant X3
transmembrane protein 38A, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
trimeric intracellular cation channel type A isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 14% coverage of the annotated genomic feature by RNAseq alignments
NACHT domain- and WD repeat-containing protein 1
SIN3 transcription regulator family member B, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
SIN3 transcription regulator family member B, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
SIN3 transcription regulator family member B, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
SIN3 transcription regulator family member B, transcript variant X4
paired amphipathic helix protein Sin3b isoform X1
SIN3 transcription regulator family member B, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
SIN3 transcription regulator family member B, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
paired amphipathic helix protein Sin3b isoform X2
paired amphipathic helix protein Sin3b isoform X3
C3 and PZP like alpha-2-macroglobulin domain containing 8, transcript variant X6
C3 and PZP like alpha-2-macroglobulin domain containing 8, transcript variant X2
C3 and PZP like alpha-2-macroglobulin domain containing 8, transcript variant X3
C3 and PZP like alpha-2-macroglobulin domain containing 8, transcript variant X4
F2R like thrombin or trypsin receptor 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA isoleucine (anticodon AAU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
proteinase-activated receptor 4 isoform X1
F2R like thrombin or trypsin receptor 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
proteinase-activated receptor 4 isoform X2
C3 and PZP like alpha-2-macroglobulin domain containing 8, transcript variant X7
C3 and PZP like alpha-2-macroglobulin domain containing 8, transcript variant X5
C3 and PZP like alpha-2-macroglobulin domain containing 8, transcript variant X1
C3 and PZP like alpha-2-macroglobulin domain containing 8, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
C3 and PZP-like alpha-2-macroglobulin domain-containing protein 8 isoform X2
C3 and PZP-like alpha-2-macroglobulin domain-containing protein 8 isoform X3
C3 and PZP-like alpha-2-macroglobulin domain-containing protein 8 isoform X1
C3 and PZP like alpha-2-macroglobulin domain containing 8, transcript variant X9
C3 and PZP like alpha-2-macroglobulin domain containing 8, transcript variant X13
C3 and PZP like alpha-2-macroglobulin domain containing 8, transcript variant X10
C3 and PZP like alpha-2-macroglobulin domain containing 8, transcript variant X11
C3 and PZP like alpha-2-macroglobulin domain containing 8, transcript variant X12
C3 and PZP like alpha-2-macroglobulin domain containing 8, transcript variant X16
C3 and PZP like alpha-2-macroglobulin domain containing 8, transcript variant X15
C3 and PZP-like alpha-2-macroglobulin domain-containing protein 8 isoform X4
C3 and PZP-like alpha-2-macroglobulin domain-containing protein 8 isoform X6
C3 and PZP-like alpha-2-macroglobulin domain-containing protein 8 isoform X5
C3 and PZP like alpha-2-macroglobulin domain containing 8, transcript variant X18
C3 and PZP like alpha-2-macroglobulin domain containing 8, transcript variant X14
C3 and PZP like alpha-2-macroglobulin domain containing 8, transcript variant X17
C3 and PZP-like alpha-2-macroglobulin domain-containing protein 8 isoform X8
C3 and PZP-like alpha-2-macroglobulin domain-containing protein 8 isoform X7
C3 and PZP-like alpha-2-macroglobulin domain-containing protein 8 isoform X9
HAUS augmin like complex subunit 8, transcript variant X2
HAUS augmin like complex subunit 8, transcript variant X1
HAUS augmin-like complex subunit 8 isoform X1
HAUS augmin like complex subunit 8, transcript variant X3
HAUS augmin like complex subunit 8, transcript variant X4
HAUS augmin-like complex subunit 8 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
unconventional SNARE in the ER 1, transcript variant X1
vesicle transport protein USE1 isoform X1
unconventional SNARE in the ER 1, transcript variant X2
vesicle transport protein USE1 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 30 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
rho guanine nucleotide exchange factor 18-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
rho guanine nucleotide exchange factor 18-like, transcript variant X1
rho guanine nucleotide exchange factor 18-like isoform X2
A-kinase anchor protein 13-like isoform X1
Rho/Rac guanine nucleotide exchange factor 18, transcript variant X2
Rho/Rac guanine nucleotide exchange factor 18, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Rho/Rac guanine nucleotide exchange factor 18, transcript variant X4
Rho/Rac guanine nucleotide exchange factor 18, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
rho guanine nucleotide exchange factor 18 isoform X1
rho guanine nucleotide exchange factor 18 isoform X2
ectoderm-neural cortex protein 1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 31 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
ectoderm-neural cortex protein 1-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 30 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
ectoderm-neural cortex protein 1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 30 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
ectoderm-neural cortex protein 1-like, transcript variant X3
ectoderm-neural cortex protein 1-like, transcript variant X4
ectoderm-neural cortex protein 1-like isoform X1
ectoderm-neural cortex protein 1-like isoform X2
ectoderm-neural cortex protein 1-like isoform X3
ectoderm-neural cortex protein 1-like, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
peroxisomal membrane protein 11C-like isoform X4
testis expressed 45, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
testis expressed 45, transcript variant X3
testis expressed 45, transcript variant X2
arrestin domain containing 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
arrestin domain-containing protein 2 isoform X2
arrestin domain containing 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
arrestin domain-containing protein 2 isoform X1
microtubule associated serine/threonine kinase 3, transcript variant X1
microtubule associated serine/threonine kinase 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
microtubule associated serine/threonine kinase 3, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
microtubule-associated serine/threonine-protein kinase 3 isoform X1
microtubule-associated serine/threonine-protein kinase 3 isoform X2
microtubule-associated serine/threonine-protein kinase 3 isoform X4
microtubule associated serine/threonine kinase 3, transcript variant X3
microtubule-associated serine/threonine-protein kinase 3 isoform X3
phosphoinositide-3-kinase regulatory subunit 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 49 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
phosphatidylinositol 3-kinase regulatory subunit beta isoform X1
phosphoinositide-3-kinase regulatory subunit 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 36 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
phosphatidylinositol 3-kinase regulatory subunit beta isoform X2
gamma-interferon-inducible lysosomal thiol reductase
MPV17 mitochondrial inner membrane protein like 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
MPV17 mitochondrial inner membrane protein like 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
MPV17 mitochondrial inner membrane protein like 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 87 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
phosphodiesterase 4C, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 54 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
phosphodiesterase 4C, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 54 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
phosphodiesterase 4C, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 54 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
cAMP-specific 3',5'-cyclic phosphodiesterase 4C isoform X2
cAMP-specific 3',5'-cyclic phosphodiesterase 4C isoform X3
cAMP-specific 3',5'-cyclic phosphodiesterase 4C isoform X1
JunD proto-oncogene, AP-1 transcription factor subunit
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: transcription factor jun-D
LSM4 homolog, U6 small nuclear RNA and mRNA degradation associated
U6 snRNA-associated Sm-like protein LSm4
pyroglutamyl-peptidase I, transcript variant X3
pyroglutamyl-peptidase I, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
pyroglutamyl-peptidase I, transcript variant X4
pyroglutamyl-peptidase I, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 88% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized LOC120391757, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
uncharacterized LOC120391757, transcript variant X1
uncharacterized protein LOC120391757 isoform X1
uncharacterized protein LOC120391757 isoform X2
single stranded DNA binding protein 4, transcript variant X4
single stranded DNA binding protein 4, transcript variant X2
single stranded DNA binding protein 4, transcript variant X1
single stranded DNA binding protein 4, transcript variant X3
single-stranded DNA-binding protein 4 isoform X1
single-stranded DNA-binding protein 4 isoform X3
single-stranded DNA-binding protein 4 isoform X2
single-stranded DNA-binding protein 4 isoform X4
single stranded DNA binding protein 4, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
single-stranded DNA-binding protein 4 isoform X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
uncharacterized LOC120391764, transcript variant X1
uncharacterized LOC120391764, transcript variant X2
uncharacterized LOC120391764, transcript variant X3
FKBP prolyl isomerase 8, transcript variant X2
FKBP prolyl isomerase 8, transcript variant X1
FKBP prolyl isomerase 8, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
FKBP prolyl isomerase 8, transcript variant X3
peptidyl-prolyl cis-trans isomerase FKBP8
KxDL motif containing 1, transcript variant X3
KxDL motif containing 1, transcript variant X1
KxDL motif containing 1, transcript variant X2
ubiquitin A-52 residue ribosomal protein fusion product 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 40 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
required for excision 1-B domain containing
required for excision 1-B domain-containing protein
cytokine receptor like factor 1, transcript variant X1
cytokine receptor like factor 1, transcript variant X2
cytokine receptor-like factor 1 isoform X1
cytokine receptor-like factor 1 isoform X2
uncharacterized LOC120391666, transcript variant X1
uncharacterized LOC120391666, transcript variant X2
uncharacterized LOC120391666, transcript variant X3
transmembrane protein 59 like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
transmembrane protein 59 like, transcript variant X2
transmembrane protein 59-like isoform X1
transmembrane protein 59-like isoform X2
kelch like family member 26, transcript variant X2
kelch like family member 26, transcript variant X5
kelch like family member 26, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
kelch like family member 26, transcript variant X3
kelch like family member 26, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
kelch like family member 26, transcript variant X6
CREB regulated transcription coactivator 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
CREB regulated transcription coactivator 1, transcript variant X1
CREB regulated transcription coactivator 1, transcript variant X3
CREB-regulated transcription coactivator 1 isoform X1
CREB-regulated transcription coactivator 1 isoform X2
CREB regulated transcription coactivator 1, transcript variant X8
CREB regulated transcription coactivator 1, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
CREB-regulated transcription coactivator 1 isoform X4
CREB regulated transcription coactivator 1, transcript variant X4
CREB regulated transcription coactivator 1, transcript variant X6
CREB-regulated transcription coactivator 1 isoform X3
CREB-regulated transcription coactivator 1 isoform X5
CREB regulated transcription coactivator 1, transcript variant X7
CREB-regulated transcription coactivator 1 isoform X6
cartilage oligomeric matrix protein, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
cartilage oligomeric matrix protein, transcript variant X1
cartilage oligomeric matrix protein, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
cartilage oligomeric matrix protein, transcript variant X8
cartilage oligomeric matrix protein, transcript variant X5
cartilage oligomeric matrix protein, transcript variant X4
cartilage oligomeric matrix protein, transcript variant X9
cartilage oligomeric matrix protein, transcript variant X7
cartilage oligomeric matrix protein, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
cartilage oligomeric matrix protein isoform X2
cartilage oligomeric matrix protein isoform X1
cartilage oligomeric matrix protein isoform X3
UPF1 RNA helicase and ATPase, transcript variant X1
UPF1 RNA helicase and ATPase, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
regulator of nonsense transcripts 1 isoform X1
regulator of nonsense transcripts 1 isoform X2
embryonic growth/differentiation factor 1
ceramide synthase 1, transcript variant X1
ceramide synthase 1, transcript variant X2
probable ATP-dependent RNA helicase DDX49
homer scaffold protein 3, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
homer scaffold protein 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 28 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
homer scaffold protein 3, transcript variant X3
homer scaffold protein 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 28 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
semaphorin-4E-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
semaphorin-4E-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
semaphorin-4E-like, transcript variant X2
semaphorin-4E-like, transcript variant X3
semaphorin-4E-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
semaphorin-4E-like, transcript variant X6
SURP and G-patch domain containing 2, transcript variant X2
SURP and G-patch domain containing 2, transcript variant X3
SURP and G-patch domain containing 2, transcript variant X1
SURP and G-patch domain-containing protein 2
armadillo repeat containing 6, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
armadillo repeat containing 6, transcript variant X2
armadillo repeat containing 6, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
armadillo repeat containing 6, transcript variant X1
armadillo repeat containing 6, transcript variant X5
uncharacterized LOC120391816, transcript variant X3
uncharacterized LOC120391816, transcript variant X1
uncharacterized LOC120391816, transcript variant X2
uncharacterized protein LOC120391816 isoform X3
uncharacterized protein LOC120391816 isoform X1
uncharacterized protein LOC120391816 isoform X2
solute carrier family 25 member 42, transcript variant X2
solute carrier family 25 member 42, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
mitochondrial coenzyme A transporter SLC25A42 isoform X1
mitochondrial coenzyme A transporter SLC25A42 isoform X2
transmembrane protein 161A, transcript variant X1
transmembrane protein 161A, transcript variant X2
myocyte enhancer factor 2B, transcript variant X1
myocyte enhancer factor 2B, transcript variant X2
myocyte-specific enhancer factor 2B isoform X2
myocyte-specific enhancer factor 2B isoform X1
BLOC-1 related complex subunit 8, transcript variant X1
BLOC-1 related complex subunit 8, transcript variant X2
regulatory factor X associated ankyrin containing protein, transcript variant X5
regulatory factor X associated ankyrin containing protein, transcript variant X2
regulatory factor X associated ankyrin containing protein, transcript variant X4
regulatory factor X associated ankyrin containing protein, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
regulatory factor X associated ankyrin containing protein, transcript variant X7
regulatory factor X associated ankyrin containing protein, transcript variant X9
regulatory factor X associated ankyrin containing protein, transcript variant X6
regulatory factor X associated ankyrin containing protein, transcript variant X8
regulatory factor X associated ankyrin containing protein, transcript variant X1
nuclear receptor 2C2 associated protein, transcript variant X5
nuclear receptor 2C2 associated protein, transcript variant X4
nuclear receptor 2C2 associated protein, transcript variant X3
nuclear receptor 2C2 associated protein, transcript variant X1
nuclear receptor 2C2-associated protein isoform X1
nuclear receptor 2C2-associated protein isoform X3
nuclear receptor 2C2 associated protein, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
nuclear receptor 2C2-associated protein isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 48 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 44 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
hyaluronan and proteoglycan link protein 4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
SURP and G-patch domain-containing protein 1
uncharacterized LOC120391637, transcript variant X2
uncharacterized LOC120391637, transcript variant X1
GATA zinc finger domain containing 2A, transcript variant X4
GATA zinc finger domain containing 2A, transcript variant X9
GATA zinc finger domain containing 2A, transcript variant X11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
GATA zinc finger domain containing 2A, transcript variant X8
GATA zinc finger domain containing 2A, transcript variant X10
GATA zinc finger domain containing 2A, transcript variant X12
GATA zinc finger domain containing 2A, transcript variant X13
GATA zinc finger domain containing 2A, transcript variant X7
GATA zinc finger domain containing 2A, transcript variant X2
GATA zinc finger domain containing 2A, transcript variant X3
GATA zinc finger domain containing 2A, transcript variant X1
GATA zinc finger domain containing 2A, transcript variant X6
GATA zinc finger domain containing 2A, transcript variant X5
transcriptional repressor p66-alpha isoform X1
transcriptional repressor p66-alpha isoform X4
transcriptional repressor p66-alpha isoform X5
transcriptional repressor p66-alpha isoform X2
transcriptional repressor p66-alpha isoform X6
transcriptional repressor p66-alpha isoform X3
GATA zinc finger domain containing 2A, transcript variant X14
transcriptional repressor p66-alpha isoform X7
uncharacterized LOC120391638, transcript variant X2
uncharacterized LOC120391638, transcript variant X1
NADH:ubiquinone oxidoreductase subunit A13
NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 13
YjeF N-terminal domain containing 3, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
YjeF N-terminal domain containing 3, transcript variant X5
YjeF N-terminal domain containing 3, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
YjeF N-terminal domain containing 3, transcript variant X4
YjeF N-terminal domain containing 3, transcript variant X8
YjeF N-terminal domain containing 3, transcript variant X7
yjeF N-terminal domain-containing protein 3 isoform X4
yjeF N-terminal domain-containing protein 3 isoform X5
YjeF N-terminal domain containing 3, transcript variant X9
YjeF N-terminal domain containing 3, transcript variant X2
YjeF N-terminal domain containing 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
yjeF N-terminal domain-containing protein 3 isoform X2
yjeF N-terminal domain-containing protein 3 isoform X1
yjeF N-terminal domain-containing protein 3 isoform X6
yjeF N-terminal domain-containing protein 3 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC120391918, transcript variant X1
uncharacterized LOC120391918, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 92% coverage of the annotated genomic feature by RNAseq alignments
coiled-coil domain-containing protein 194
GTP binding protein 3, mitochondrial, transcript variant X2
GTP binding protein 3, mitochondrial, transcript variant X1
tRNA modification GTPase GTPBP3, mitochondrial isoform X2
tRNA modification GTPase GTPBP3, mitochondrial isoform X1
mitochondrial ribosomal protein L34, transcript variant X1
DET1 and DDB1 associated 1, transcript variant X3
DET1 and DDB1 associated 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
DET1 and DDB1 associated 1, transcript variant X2
DET1- and DDB1-associated protein 1 isoform X3
DET1- and DDB1-associated protein 1 isoform X1
DET1- and DDB1-associated protein 1 isoform X2
mitochondrial ribosomal protein L34, transcript variant X2
39S ribosomal protein L34, mitochondrial
abhydrolase domain containing 8, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
abhydrolase domain containing 8, transcript variant X2
abhydrolase domain containing 8, transcript variant X4
abhydrolase domain containing 8, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
abhydrolase domain containing 8, transcript variant X5
abhydrolase domain containing 8, transcript variant X8
abhydrolase domain containing 8, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
abhydrolase domain containing 8, transcript variant X9
abhydrolase domain containing 8, transcript variant X10
abhydrolase domain containing 8, transcript variant X1
ankyrin repeat and LEM domain containing 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
ankyrin repeat and LEM domain containing 1, transcript variant X1
ankyrin repeat and LEM domain-containing protein 1
BRISC and BRCA1 A complex member 1, transcript variant X1
BRISC and BRCA1 A complex member 1, transcript variant X2
BRISC and BRCA1 A complex member 1, transcript variant X3
AT-rich interaction domain 3A, transcript variant X3
AT-rich interaction domain 3A, transcript variant X1
AT-rich interaction domain 3A, transcript variant X2
AT-rich interactive domain-containing protein 3A isoform X1
AT-rich interaction domain 3A, transcript variant X4
AT-rich interactive domain-containing protein 3A isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
glutamate ionotropic receptor NMDA type subunit 3B
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 91% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
transmembrane protein 259, transcript variant X2
transmembrane protein 259, transcript variant X1
Derived by automated computational analysis using gene prediction method: cmsearch.
COORDINATES: nucleotide motif:Rfam:12.0:RF00026
ATP binding cassette subfamily A member 7, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 39 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
ATP binding cassette subfamily A member 7, transcript variant X1
ATP binding cassette subfamily A member 7, transcript variant X2
phospholipid-transporting ATPase ABCA7 isoform X2
phospholipid-transporting ATPase ABCA7 isoform X1
phospholipid-transporting ATPase ABCA7 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 34 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Rho GTPase activating protein 45, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
rho GTPase-activating protein 45 isoform X2
Rho GTPase activating protein 45, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
rho GTPase-activating protein 45 isoform X1
RNA polymerase II, I and III subunit E, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
RNA polymerase II, I and III subunit E, transcript variant X2
DNA-directed RNA polymerases I, II, and III subunit RPABC1
phospholipid hydroperoxide glutathione peroxidase
strawberry notch homolog 2, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
strawberry notch homolog 2, transcript variant X3
strawberry notch homolog 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
strawberry notch homolog 2, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
strawberry notch homolog 2, transcript variant X8
strawberry notch homolog 2, transcript variant X2
strawberry notch homolog 2, transcript variant X6
strawberry notch homolog 2, transcript variant X5
strawberry notch homolog 2, transcript variant X14
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
strawberry notch homolog 2, transcript variant X9
strawberry notch homolog 2, transcript variant X13
strawberry notch homolog 2, transcript variant X4
strawberry notch homolog 2, transcript variant X12
strawberry notch homolog 2, transcript variant X11
strawberry notch homolog 2, transcript variant X15
strawberry notch homolog 2, transcript variant X16
protein strawberry notch homolog 2 isoform X2
protein strawberry notch homolog 2 isoform X1
protein strawberry notch homolog 2 isoform X3
protein strawberry notch homolog 2 isoform X4
serine/threonine kinase 11, transcript variant X1
serine/threonine kinase 11, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
serine/threonine kinase 11, transcript variant X2
serine/threonine-protein kinase STK11 isoform X1
serine/threonine-protein kinase STK11 isoform X2
CACN subunit beta associated regulatory protein, transcript variant X7
CACN subunit beta associated regulatory protein, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
CACN subunit beta associated regulatory protein, transcript variant X3
CACN subunit beta associated regulatory protein, transcript variant X1
CACN subunit beta associated regulatory protein, transcript variant X8
CACN subunit beta associated regulatory protein, transcript variant X9
CACN subunit beta associated regulatory protein, transcript variant X4
CACN subunit beta associated regulatory protein, transcript variant X2
CACN subunit beta associated regulatory protein, transcript variant X5
voltage-dependent calcium channel beta subunit-associated regulatory protein isoform X3
voltage-dependent calcium channel beta subunit-associated regulatory protein isoform X1
voltage-dependent calcium channel beta subunit-associated regulatory protein isoform X4
voltage-dependent calcium channel beta subunit-associated regulatory protein isoform X2
ATP synthase subunit delta, mitochondrial
cold inducible RNA binding protein, transcript variant X5
cold inducible RNA binding protein, transcript variant X6
cold inducible RNA binding protein, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
cold inducible RNA binding protein, transcript variant X1
cold inducible RNA binding protein, transcript variant X2
cold inducible RNA binding protein, transcript variant X4
cold inducible RNA binding protein, transcript variant X3
cold-inducible RNA-binding protein isoform X3
cold-inducible RNA-binding protein isoform X4
cold-inducible RNA-binding protein isoform X1
cold-inducible RNA-binding protein isoform X2
family with sequence similarity 174 member C, transcript variant X1
family with sequence similarity 174 member C, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
calcium/calmodulin-dependent protein kinase type IV-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
PWWP domain containing 3A, DNA repair factor, transcript variant X1
PWWP domain containing 3A, DNA repair factor, transcript variant X7
PWWP domain containing 3A, DNA repair factor, transcript variant X10
PWWP domain containing 3A, DNA repair factor, transcript variant X8
PWWP domain containing 3A, DNA repair factor, transcript variant X2
PWWP domain containing 3A, DNA repair factor, transcript variant X6
PWWP domain containing 3A, DNA repair factor, transcript variant X4
PWWP domain containing 3A, DNA repair factor, transcript variant X3
PWWP domain containing 3A, DNA repair factor, transcript variant X5
PWWP domain containing 3A, DNA repair factor, transcript variant X9
PWWP domain-containing DNA repair factor 3A
transfer RNA phenylalanine (anticodon GAA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA asparagine (anticodon GUU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
NADH:ubiquinone oxidoreductase core subunit S7
NADH dehydrogenase [ubiquinone] iron-sulfur protein 7, mitochondrial
guanidinoacetate N-methyltransferase, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
guanidinoacetate N-methyltransferase, transcript variant X2
guanidinoacetate N-methyltransferase isoform X1
guanidinoacetate N-methyltransferase isoform X2
DAZ associated protein 1, transcript variant X3
DAZ associated protein 1, transcript variant X4
DAZ associated protein 1, transcript variant X1
DAZ associated protein 1, transcript variant X2
DAZ associated protein 1, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 32% coverage of the annotated genomic feature by RNAseq alignments
APC regulator of WNT signaling pathway 2, transcript variant X1
adenomatous polyposis coli protein 2 isoform X1
APC regulator of WNT signaling pathway 2, transcript variant X5
APC regulator of WNT signaling pathway 2, transcript variant X3
APC regulator of WNT signaling pathway 2, transcript variant X2
APC regulator of WNT signaling pathway 2, transcript variant X4
adenomatous polyposis coli protein 2 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
chromosome 26 C19orf25 homolog, transcript variant X1
chromosome 26 C19orf25 homolog, transcript variant X2
receptor accessory protein 6, transcript variant X1
receptor accessory protein 6, transcript variant X2
receptor expression-enhancing protein 6 isoform X2
receptor expression-enhancing protein 6 isoform X1
proprotein convertase subtilisin/kexin type 4, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 34 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
proprotein convertase subtilisin/kexin type 4, transcript variant X3
proprotein convertase subtilisin/kexin type 4 isoform X3
proprotein convertase subtilisin/kexin type 4, transcript variant X4
proprotein convertase subtilisin/kexin type 4, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 42 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
proprotein convertase subtilisin/kexin type 4, transcript variant X2
proprotein convertase subtilisin/kexin type 4 isoform X1
proprotein convertase subtilisin/kexin type 4 isoform X2
proprotein convertase subtilisin/kexin type 4, transcript variant X5
proprotein convertase subtilisin/kexin type 4 isoform X4
CTD small phosphatase-like protein 2-B, transcript variant X5
CTD small phosphatase-like protein 2-B, transcript variant X4
CTD small phosphatase-like protein 2-B, transcript variant X3
CTD small phosphatase-like protein 2-B, transcript variant X2
CTD small phosphatase-like protein 2-B, transcript variant X1
CTD small phosphatase-like protein 2-B, transcript variant X6
CTD small phosphatase-like protein 2-B isoform X5
CTD small phosphatase-like protein 2-B isoform X4
CTD small phosphatase-like protein 2-B isoform X3
CTD small phosphatase-like protein 2-B isoform X2
CTD small phosphatase-like protein 3 isoform X1
CTD small phosphatase-like protein 2-B isoform X6
polo like kinase 5 (inactive), transcript variant X1
inactive serine/threonine-protein kinase PLK5 isoform X1
polo like kinase 5 (inactive), transcript variant X2
inactive serine/threonine-protein kinase PLK5 isoform X2
small glutamine rich tetratricopeptide repeat co-chaperone alpha, transcript variant X2
small glutamine rich tetratricopeptide repeat co-chaperone alpha, transcript variant X1
small glutamine-rich tetratricopeptide repeat-containing protein alpha
DIRAS family GTPase 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 37 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
solute carrier family 39 member 3, transcript variant X2
solute carrier family 39 member 3, transcript variant X1
solute carrier family 39 member 3, transcript variant X3
solute carrier family 39 member 3, transcript variant X4
DIRAS family GTPase 1, transcript variant X3
DIRAS family GTPase 1, transcript variant X2
DIRAS family GTPase 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 37 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
G protein subunit gamma 7, transcript variant X5
G protein subunit gamma 7, transcript variant X10
G protein subunit gamma 7, transcript variant X9
G protein subunit gamma 7, transcript variant X4
G protein subunit gamma 7, transcript variant X2
G protein subunit gamma 7, transcript variant X3
G protein subunit gamma 7, transcript variant X6
G protein subunit gamma 7, transcript variant X7
G protein subunit gamma 7, transcript variant X8
G protein subunit gamma 7, transcript variant X1
guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-7
uncharacterized LOC120391781, transcript variant X2
uncharacterized LOC120391781, transcript variant X1
growth arrest and DNA damage inducible beta, transcript variant X1
growth arrest and DNA damage inducible beta, transcript variant X2
growth arrest and DNA damage-inducible protein GADD45 beta isoform X2
growth arrest and DNA damage-inducible protein GADD45 beta isoform X1
survival motor neuron protein 1-like, transcript variant X1
survival motor neuron protein 1-like, transcript variant X2
survival motor neuron protein 1-like isoform X1
survival motor neuron protein 1-like, transcript variant X3
survival motor neuron protein 1-like isoform X2
cocaine- and amphetamine-regulated transcript protein-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
zona pellucida sperm-binding protein 4-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
FCH and mu domain containing endocytic adaptor 1, transcript variant X1
FCH and mu domain containing endocytic adaptor 1, transcript variant X3
FCH and mu domain containing endocytic adaptor 1, transcript variant X4
FCH and mu domain containing endocytic adaptor 1, transcript variant X2
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3, transcript variant X16
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3, transcript variant X8
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3, transcript variant X2
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3, transcript variant X9
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3, transcript variant X1
N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase 3 isoform X1
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3, transcript variant X10
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3, transcript variant X11
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3, transcript variant X3
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3, transcript variant X13
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3, transcript variant X7
N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase 3 isoform X2
N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase 3 isoform X5
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3, transcript variant X12
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3, transcript variant X4
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3, transcript variant X14
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3, transcript variant X15
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3, transcript variant X6
N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase 3 isoform X4
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3, transcript variant X5
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3, transcript variant X17
N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase 3 isoform X3
N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase 3 isoform X6
N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase 3 isoform X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 44 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 32 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
coiled-coil domain containing 124, transcript variant X2
coiled-coil domain containing 124, transcript variant X3
coiled-coil domain containing 124, transcript variant X1
coiled-coil domain-containing protein 124 isoform X1
coiled-coil domain-containing protein 124 isoform X2
potassium calcium-activated channel subfamily N member 1, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 34 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
potassium calcium-activated channel subfamily N member 1, transcript variant X1
potassium calcium-activated channel subfamily N member 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
potassium calcium-activated channel subfamily N member 1, transcript variant X2
potassium calcium-activated channel subfamily N member 1, transcript variant X3
potassium calcium-activated channel subfamily N member 1, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 37 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
small conductance calcium-activated potassium channel protein 1 isoform X3
small conductance calcium-activated potassium channel protein 1 isoform X1
small conductance calcium-activated potassium channel protein 1 isoform X2
MARVEL domain-containing protein 2-like, transcript variant X4
MARVEL domain-containing protein 2-like, transcript variant X1
MARVEL domain-containing protein 2-like, transcript variant X2
MARVEL domain-containing protein 2-like, transcript variant X3
nuclear receptor subfamily 2 group F member 6, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 35 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
nuclear receptor subfamily 2 group F member 6, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 35 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
nuclear receptor subfamily 2 group F member 6, transcript variant X3
nuclear receptor subfamily 2 group F member 6 isoform X1
nuclear receptor subfamily 2 group F member 6 isoform X2
Usher syndrome type-1C protein-binding protein 1-like, transcript variant X2
Usher syndrome type-1C protein-binding protein 1-like, transcript variant X4
Usher syndrome type-1C protein-binding protein 1-like, transcript variant X3
Usher syndrome type-1C protein-binding protein 1-like, transcript variant X1
Usher syndrome type-1C protein-binding protein 1-like, transcript variant X5
Usher syndrome type-1C protein-binding protein 1-like, transcript variant X6
Usher syndrome type-1C protein-binding protein 1-like isoform X1
Usher syndrome type-1C protein-binding protein 1-like isoform X2
R3H domain containing 4, transcript variant X1
R3H domain containing 4, transcript variant X3
R3H domain containing 4, transcript variant X4
R3H domain containing 4, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
R3H domain-containing protein 4 isoform X1
R3H domain-containing protein 4 isoform X2
R3H domain-containing protein 4 isoform X3
R3H domain-containing protein 4 isoform X4
mediator complex subunit 16, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 33 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
mediator complex subunit 16, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 33 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
mediator complex subunit 16, transcript variant X3
mediator complex subunit 16, transcript variant X5
mediator complex subunit 16, transcript variant X6
mediator complex subunit 16, transcript variant X1
mediator of RNA polymerase II transcription subunit 16 isoform X1
mediator of RNA polymerase II transcription subunit 16 isoform X2
mediator of RNA polymerase II transcription subunit 16 isoform X3
phospholipid phosphatase related 3, transcript variant X1
phospholipid phosphatase related 3, transcript variant X7
phospholipid phosphatase related 3, transcript variant X3
phospholipid phosphatase related 3, transcript variant X4
phospholipid phosphatase related 3, transcript variant X5
phospholipid phosphatase related 3, transcript variant X2
phospholipid phosphatase related 3, transcript variant X6
phospholipid phosphatase-related protein type 3 isoform X1
phospholipid phosphatase-related protein type 3 isoform X2
polypyrimidine tract binding protein 1, transcript variant X1
polypyrimidine tract binding protein 1, transcript variant X2
polypyrimidine tract-binding protein 1 isoform X1
polypyrimidine tract-binding protein 1 isoform X2
uncharacterized protein KIAA1958-like, transcript variant X2
uncharacterized protein KIAA1958-like, transcript variant X5
uncharacterized protein KIAA1958-like, transcript variant X1
uncharacterized protein KIAA1958-like, transcript variant X6
uncharacterized protein KIAA1958-like, transcript variant X3
uncharacterized protein KIAA1958-like, transcript variant X7
uncharacterized protein KIAA1958-like, transcript variant X4
mitotic spindle positioning, transcript variant X3
mitotic spindle positioning, transcript variant X1
mitotic spindle positioning, transcript variant X2
mitotic spindle positioning, transcript variant X4
mitotic interactor and substrate of PLK1 isoform X1
mitotic interactor and substrate of PLK1 isoform X2
serine protease 57, transcript variant X2
serine protease 57, transcript variant X1
ring finger protein 126, transcript variant X1
E3 ubiquitin-protein ligase RNF126 isoform X1
ring finger protein 126, transcript variant X2
E3 ubiquitin-protein ligase RNF126 isoform X2
fibroblast growth factor 22, transcript variant X2
fibroblast growth factor 22, transcript variant X1
DNA-directed RNA polymerase, mitochondrial
hyperpolarization activated cyclic nucleotide gated potassium and sodium channel 2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
hyperpolarization activated cyclic nucleotide gated potassium and sodium channel 2, transcript variant X3
hyperpolarization activated cyclic nucleotide gated potassium and sodium channel 2, transcript variant X2
hyperpolarization activated cyclic nucleotide gated potassium and sodium channel 2, transcript variant X1
potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 2 isoform X2
potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 2 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 94% coverage of the annotated genomic feature by RNAseq alignments
cell division cycle 34, ubiqiutin conjugating enzyme
tubulin polyglutamylase complex subunit 1, transcript variant X2
tubulin polyglutamylase complex subunit 1, transcript variant X1
tubulin polyglutamylase complex subunit 1 isoform X2
tubulin polyglutamylase complex subunit 1 isoform X1
zinc finger protein 79-like, transcript variant X1
zinc finger protein 79-like, transcript variant X2
mucosal vascular addressin cell adhesion molecule 1, transcript variant X1
mucosal vascular addressin cell adhesion molecule 1, transcript variant X2
mucosal addressin cell adhesion molecule 1 isoform X2
mucosal addressin cell adhesion molecule 1 isoform X1
hippocampus abundant transcript 1 protein-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
hippocampus abundant transcript 1 protein-like, transcript variant X3
hippocampus abundant transcript 1 protein-like, transcript variant X2
hippocampus abundant transcript 1 protein-like, transcript variant X1
hippocampus abundant transcript 1 protein-like isoform X3
hippocampus abundant transcript 1 protein-like isoform X2
hippocampus abundant transcript 1 protein-like isoform X1
hippocampus abundant transcript 1 protein-like isoform X4
outer dense fiber of sperm tails 3 like 2
outer dense fiber protein 3-like protein 2
SHC adaptor protein 2, transcript variant X3
SHC adaptor protein 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 32 Proteins, and 94% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
SHC adaptor protein 2, transcript variant X1
C2 calcium dependent domain containing 4C
C2 calcium-dependent domain-containing protein 4C
uncharacterized LOC120391773, transcript variant X3
uncharacterized LOC120391773, transcript variant X1
uncharacterized LOC120391773, transcript variant X2
insulin gene enhancer protein ISL-2-like, transcript variant X3
insulin gene enhancer protein ISL-2-like, transcript variant X6
insulin gene enhancer protein ISL-2-like, transcript variant X4
insulin gene enhancer protein ISL-2-like, transcript variant X2
insulin gene enhancer protein ISL-2-like, transcript variant X5
insulin gene enhancer protein ISL-2-like, transcript variant X1
insulin gene enhancer protein ISL-2-like isoform X1
insulin gene enhancer protein ISL-2-like isoform X2
theg spermatid protein, transcript variant X2
theg spermatid protein, transcript variant X5
theg spermatid protein, transcript variant X1
theg spermatid protein, transcript variant X4
theg spermatid protein, transcript variant X3
testicular haploid expressed gene protein isoform X2
testicular haploid expressed gene protein isoform X1
MIER family member 2, transcript variant X2
mesoderm induction early response protein 2 isoform X2
MIER family member 2, transcript variant X1
MIER family member 2, transcript variant X3
MIER family member 2, transcript variant X4
mesoderm induction early response protein 2 isoform X1
mesoderm induction early response protein 2 isoform X3
mesoderm induction early response protein 2 isoform X4
MIER family member 2, transcript variant X5
mesoderm induction early response protein 2 isoform X5
granulocyte colony-stimulating factor receptor-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 74% coverage of the annotated genomic feature by RNAseq alignments
interleukin-6 receptor subunit beta-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 97% coverage of the annotated genomic feature by RNAseq alignments
transducin-like enhancer protein 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 44 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
transducin-like enhancer protein 1, transcript variant X2
transducin-like enhancer protein 1 isoform X1
transducin-like enhancer protein 1 isoform X2
transducin-like enhancer protein 1, transcript variant X3
transducin-like enhancer protein 1 isoform X3
TLE family member 2, transcriptional corepressor, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 35 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
TLE family member 2, transcriptional corepressor, transcript variant X2
TLE family member 2, transcriptional corepressor, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 35 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
TLE family member 2, transcriptional corepressor, transcript variant X1
TLE family member 2, transcriptional corepressor, transcript variant X5
TLE family member 2, transcriptional corepressor, transcript variant X6
TLE family member 2, transcriptional corepressor, transcript variant X7
TLE family member 2, transcriptional corepressor, transcript variant X8
TLE family member 2, transcriptional corepressor, transcript variant X9
transducin-like enhancer protein 2 isoform X2
transducin-like enhancer protein 2 isoform X1
transducin-like enhancer protein 2 isoform X3
transducin-like enhancer protein 2 isoform X5
transducin-like enhancer protein 2 isoform X4
TLE family member 5, transcriptional modulator, transcript variant X2
TLE family member 5, transcriptional modulator, transcript variant X1
G protein subunit alpha 11, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
G protein subunit alpha 11, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 153 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
guanine nucleotide-binding protein subunit alpha-11 isoform X1
guanine nucleotide-binding protein subunit alpha-11 isoform X2
G protein subunit alpha 15, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 118 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
G protein subunit alpha 15, transcript variant X1
G protein subunit alpha 15, transcript variant X2
guanine nucleotide-binding protein subunit alpha-15 isoform X1
G protein subunit alpha 15, transcript variant X4
guanine nucleotide-binding protein subunit alpha-15 isoform X2
activated RNA polymerase II transcriptional coactivator p15-like, transcript variant X1
activated RNA polymerase II transcriptional coactivator p15-like, transcript variant X2
activated RNA polymerase II transcriptional coactivator p15-like, transcript variant X3
activated RNA polymerase II transcriptional coactivator p15-like
CUGBP Elav-like family member 5, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 58 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
CUGBP Elav-like family member 5, transcript variant X3
CUGBP Elav-like family member 5, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 75 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
CUGBP Elav-like family member 5, transcript variant X4
CUGBP Elav-like family member 5 isoform X1
CUGBP Elav-like family member 5 isoform X3
CUGBP Elav-like family member 5 isoform X2
CUGBP Elav-like family member 5 isoform X4
hydroxysteroid 11-beta dehydrogenase 1 like, transcript variant X15
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
hydroxysteroid 11-beta-dehydrogenase 1-like protein isoform X3
hydroxysteroid 11-beta dehydrogenase 1 like, transcript variant X11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
hydroxysteroid 11-beta dehydrogenase 1 like, transcript variant X1
hydroxysteroid 11-beta dehydrogenase 1 like, transcript variant X14
hydroxysteroid 11-beta dehydrogenase 1 like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
hydroxysteroid 11-beta dehydrogenase 1 like, transcript variant X7
hydroxysteroid 11-beta dehydrogenase 1 like, transcript variant X3
hydroxysteroid 11-beta dehydrogenase 1 like, transcript variant X8
hydroxysteroid 11-beta dehydrogenase 1 like, transcript variant X4
hydroxysteroid 11-beta dehydrogenase 1 like, transcript variant X5
hydroxysteroid 11-beta dehydrogenase 1 like, transcript variant X10
hydroxysteroid 11-beta dehydrogenase 1 like, transcript variant X9
hydroxysteroid 11-beta dehydrogenase 1 like, transcript variant X6
hydroxysteroid 11-beta dehydrogenase 1 like, transcript variant X12
hydroxysteroid 11-beta dehydrogenase 1 like, transcript variant X13
hydroxysteroid 11-beta-dehydrogenase 1-like protein isoform X1
hydroxysteroid 11-beta-dehydrogenase 1-like protein isoform X2
mitochondrial contact site and cristae organizing system subunit 13, transcript variant X2
mitochondrial contact site and cristae organizing system subunit 13, transcript variant X1
disintegrin and metalloproteinase domain-containing protein 10-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 71% coverage of the annotated genomic feature by RNAseq alignments
scaffold attachment factor B1-like, transcript variant X1
scaffold attachment factor B1-like, transcript variant X2
scaffold attachment factor B1-like isoform X1
scaffold attachment factor B1-like isoform X2
scaffold attachment factor B1-like, transcript variant X3
scaffold attachment factor B1-like, transcript variant X4
scaffold attachment factor B1-like, transcript variant X6
scaffold attachment factor B1-like isoform X3
scaffold attachment factor B1-like, transcript variant X5
scaffold attachment factor B2-like isoform X4
uncharacterized LOC120391719, transcript variant X2
uncharacterized LOC120391719, transcript variant X3
uncharacterized LOC120391719, transcript variant X1
uncharacterized LOC120391718, transcript variant X2
uncharacterized LOC120391718, transcript variant X3
uncharacterized LOC120391718, transcript variant X4
uncharacterized LOC120391718, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
transfer RNA arginine (anticodon CCU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
protein tyrosine phosphatase receptor type S, transcript variant X11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 49 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
protein tyrosine phosphatase receptor type S, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 51 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
protein tyrosine phosphatase receptor type S, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 58 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
protein tyrosine phosphatase receptor type S, transcript variant X5
protein tyrosine phosphatase receptor type S, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 54 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
protein tyrosine phosphatase receptor type S, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 52 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
protein tyrosine phosphatase receptor type S, transcript variant X13
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 53 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
protein tyrosine phosphatase receptor type S, transcript variant X9
protein tyrosine phosphatase receptor type S, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 53 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
protein tyrosine phosphatase receptor type S, transcript variant X12
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 49 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
protein tyrosine phosphatase receptor type S, transcript variant X3
protein tyrosine phosphatase receptor type S, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 51 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
protein tyrosine phosphatase receptor type S, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 51 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
receptor-type tyrosine-protein phosphatase S isoform X8
receptor-type tyrosine-protein phosphatase S isoform X1
receptor-type tyrosine-protein phosphatase S isoform X3
receptor-type tyrosine-protein phosphatase S isoform X2
receptor-type tyrosine-protein phosphatase S isoform X4
receptor-type tyrosine-protein phosphatase S isoform X5
receptor-type tyrosine-protein phosphatase S isoform X10
receptor-type tyrosine-protein phosphatase S isoform X6
receptor-type tyrosine-protein phosphatase S isoform X7
receptor-type tyrosine-protein phosphatase S isoform X9
uncharacterized LOC120391521, transcript variant X2
uncharacterized LOC120391521, transcript variant X5
uncharacterized LOC120391521, transcript variant X7
uncharacterized LOC120391521, transcript variant X6
uncharacterized LOC120391521, transcript variant X1
uncharacterized LOC120391521, transcript variant X3
uncharacterized LOC120391521, transcript variant X4
lysine demethylase 4B, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
lysine-specific demethylase 4B isoform X1
lysine demethylase 4B, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
lysine-specific demethylase 4B isoform X2
lysine demethylase 4B, transcript variant X3
lysine-specific demethylase 4B isoform X3
lysine demethylase 4B, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
lysine-specific demethylase 4B isoform X4
lysine demethylase 4B, transcript variant X5
lysine-specific demethylase 4B isoform X5
ubiquitin like with PHD and ring finger domains 1, transcript variant X3
E3 ubiquitin-protein ligase UHRF1 isoform X3
ubiquitin like with PHD and ring finger domains 1, transcript variant X2
E3 ubiquitin-protein ligase UHRF1 isoform X2
ubiquitin like with PHD and ring finger domains 1, transcript variant X1
ubiquitin like with PHD and ring finger domains 1, transcript variant X4
E3 ubiquitin-protein ligase UHRF1 isoform X1
uncharacterized LOC120391911, transcript variant X1
uncharacterized LOC120391911, transcript variant X2
TIR domain-containing adapter molecule 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC120391909, transcript variant X4
uncharacterized LOC120391909, transcript variant X2
uncharacterized LOC120391909, transcript variant X1
uncharacterized LOC120391909, transcript variant X3
transfer RNA valine (anticodon CAC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA glycine (anticodon UCC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
dipeptidyl peptidase 9, transcript variant X2
dipeptidyl peptidase 9, transcript variant X1
dipeptidyl peptidase 9, transcript variant X3
procathepsin L-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 45 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
procathepsin L-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 45 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
procathepsin L-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 45 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
procathepsin L-like, transcript variant X4
procathepsin L-like, transcript variant X2
procathepsin L-like, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 45 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
TNF alpha induced protein 8 like 1, transcript variant X2
TNF alpha induced protein 8 like 1, transcript variant X1
TNF alpha induced protein 8 like 1, transcript variant X3
TNF alpha induced protein 8 like 1, transcript variant X4
tumor necrosis factor alpha-induced protein 8-like protein 1 isoform X1
tumor necrosis factor alpha-induced protein 8-like protein 1 isoform X2
leucine rich alpha-2-glycoprotein 1, transcript variant X1
leucine rich alpha-2-glycoprotein 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 31 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 32 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments
hepatoma-derived growth factor-related protein 2 isoform X1
hepatoma-derived growth factor-related protein 2 isoform X2
UBX domain protein 6, transcript variant X3
UBX domain protein 6, transcript variant X5
UBX domain protein 6, transcript variant X7
UBX domain protein 6, transcript variant X4
UBX domain protein 6, transcript variant X6
UBX domain-containing protein 6 isoform X3
UBX domain protein 6, transcript variant X1
UBX domain protein 6, transcript variant X2
UBX domain-containing protein 6 isoform X1
UBX domain-containing protein 6 isoform X2
UBX domain-containing protein 6 isoform X4
UBX domain-containing protein 6 isoform X5
UBX domain-containing protein 6 isoform X6
chromatin assembly factor 1 subunit A, transcript variant X2
chromatin assembly factor 1 subunit A, transcript variant X1
SH3 domain containing GRB2 like 1, endophilin A2, transcript variant X1
SH3 domain containing GRB2 like 1, endophilin A2, transcript variant X3
SH3 domain containing GRB2 like 1, endophilin A2, transcript variant X2
signal transducing adaptor family member 2, transcript variant X1
signal transducing adaptor family member 2, transcript variant X2
signal-transducing adaptor protein 2 isoform X1
signal-transducing adaptor protein 2 isoform X2
signal transducing adaptor family member 2, transcript variant X3
signal-transducing adaptor protein 2 isoform X3
fibronectin type III and SPRY domain containing 1, transcript variant X1
fibronectin type III and SPRY domain containing 1, transcript variant X4
fibronectin type III and SPRY domain containing 1, transcript variant X3
fibronectin type III and SPRY domain-containing protein 1 isoform X1
fibronectin type III and SPRY domain-containing protein 1 isoform X3
fibronectin type III and SPRY domain containing 1, transcript variant X2
fibronectin type III and SPRY domain-containing protein 1 isoform X2
transmembrane and immunoglobulin domain containing 2, transcript variant X3
transmembrane and immunoglobulin domain containing 2, transcript variant X1
transmembrane and immunoglobulin domain containing 2, transcript variant X2
transmembrane and immunoglobulin domain-containing protein 2 isoform X3
transmembrane and immunoglobulin domain-containing protein 2 isoform X1
transmembrane and immunoglobulin domain-containing protein 2 isoform X2
Src homology 2 domain containing transforming protein D
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 92% coverage of the annotated genomic feature by RNAseq alignments
ankyrin repeat domain-containing protein 24
NAD-dependent protein deacetylase sirtuin-6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins
cAMP responsive element binding protein 3 like 3, transcript variant X3
cAMP responsive element binding protein 3 like 3, transcript variant X4
cAMP responsive element binding protein 3 like 3, transcript variant X1
cAMP responsive element binding protein 3 like 3, transcript variant X2
cyclic AMP-responsive element-binding protein 3-like protein 3 isoform X2
cyclic AMP-responsive element-binding protein 3-like protein 3 isoform X3
cyclic AMP-responsive element-binding protein 3-like protein 3 isoform X1
mitogen-activated protein kinase kinase 2
dual specificity mitogen-activated protein kinase kinase 2
zinc finger and BTB domain containing 7A, transcript variant X4
zinc finger and BTB domain containing 7A, transcript variant X1
zinc finger and BTB domain containing 7A, transcript variant X2
zinc finger and BTB domain containing 7A, transcript variant X3
zinc finger and BTB domain-containing protein 7A
protein inhibitor of activated STAT 4, transcript variant X1
protein inhibitor of activated STAT 4, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
eukaryotic translation elongation factor 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 36 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
COORDINATES: nucleotide motif:Rfam:12.0:RF00440
death associated protein kinase 3, transcript variant X1
death associated protein kinase 3, transcript variant X2
uncharacterized LOC120391710, transcript variant X1
nicotinamide riboside kinase 2, transcript variant X3
nicotinamide riboside kinase 2, transcript variant X2
nicotinamide riboside kinase 2, transcript variant X1
nicotinamide riboside kinase 2 isoform X1
nicotinamide riboside kinase 2 isoform X2
uncharacterized LOC120391710, transcript variant X2
ATCAY kinesin light chain interacting caytaxin, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
ATCAY kinesin light chain interacting caytaxin, transcript variant X1
3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 41 Proteins
4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT6-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 37 Proteins, and 16% coverage of the annotated genomic feature by RNAseq alignments
dihydrouridine synthase 3 like, transcript variant X2
dihydrouridine synthase 3 like, transcript variant X1
tRNA-dihydrouridine(47) synthase [NAD(P)(+)]-like isoform X1
tRNA-dihydrouridine(47) synthase [NAD(P)(+)]-like isoform X2
uncharacterized LOC120391810, transcript variant X2
uncharacterized LOC120391810, transcript variant X1
uncharacterized LOC120391810, transcript variant X3
regulatory factor X2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
regulatory factor X2, transcript variant X2
regulatory factor X2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
regulatory factor X2, transcript variant X1
regulatory factor X2, transcript variant X5
acyl-CoA synthetase bubblegum family member 2, transcript variant X2
acyl-CoA synthetase bubblegum family member 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 28 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
long-chain-fatty-acid--CoA ligase ACSBG2 isoform X1
long-chain-fatty-acid--CoA ligase ACSBG2 isoform X2
acyl-CoA synthetase bubblegum family member 2, transcript variant X5
acyl-CoA synthetase bubblegum family member 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
acyl-CoA synthetase bubblegum family member 2, transcript variant X4
long-chain-fatty-acid--CoA ligase ACSBG2 isoform X3
MLLT1 super elongation complex subunit, transcript variant X3
MLLT1 super elongation complex subunit, transcript variant X5
MLLT1 super elongation complex subunit, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
MLLT1 super elongation complex subunit, transcript variant X6
MLLT1 super elongation complex subunit, transcript variant X7
MLLT1 super elongation complex subunit, transcript variant X1
MLLT1 super elongation complex subunit, transcript variant X10
MLLT1 super elongation complex subunit, transcript variant X9
MLLT1 super elongation complex subunit, transcript variant X4
MLLT1 super elongation complex subunit, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments
acidic leucine-rich nuclear phosphoprotein 32 family member B, transcript variant X3
acidic leucine-rich nuclear phosphoprotein 32 family member B, transcript variant X2
acidic leucine-rich nuclear phosphoprotein 32 family member B, transcript variant X4
acidic leucine-rich nuclear phosphoprotein 32 family member B, transcript variant X1
acidic leucine-rich nuclear phosphoprotein 32 family member B isoform X1
acidic leucine-rich nuclear phosphoprotein 32 family member B isoform X3
acidic leucine-rich nuclear phosphoprotein 32 family member B isoform X2
acidic leucine-rich nuclear phosphoprotein 32 family member B isoform X4
zinc finger protein 414, transcript variant X2
zinc finger protein 414, transcript variant X3
zinc finger protein 414, transcript variant X1
zinc finger protein 414, transcript variant X4
ADAM metallopeptidase with thrombospondin type 1 motif 10, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
ADAM metallopeptidase with thrombospondin type 1 motif 10, transcript variant X2
A disintegrin and metalloproteinase with thrombospondin motifs 10 isoform X1
A disintegrin and metalloproteinase with thrombospondin motifs 10 isoform X2
tyrosine-protein kinase ZAP-70, transcript variant X5
tyrosine-protein kinase ZAP-70, transcript variant X2
tyrosine-protein kinase ZAP-70, transcript variant X1
tyrosine-protein kinase ZAP-70 isoform X1
tyrosine-protein kinase ZAP-70, transcript variant X3
tyrosine-protein kinase ZAP-70, transcript variant X4
tyrosine-protein kinase ZAP-70, transcript variant X6
tyrosine-protein kinase ZAP-70, transcript variant X7
tyrosine-protein kinase ZAP-70 isoform X2
tyrosine-protein kinase ZAP-70 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 49 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 87% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 75% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 49% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 64% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 91% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 88% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 62% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 92% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 16% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC120391806, transcript variant X1
uncharacterized LOC120391806, transcript variant X2
uncharacterized protein LOC120391806 isoform X1
uncharacterized protein LOC120391806 isoform X2
leucine rich repeat and Ig domain containing 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 33 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
leucine rich repeat and Ig domain containing 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 33 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
leucine-rich repeat and immunoglobulin-like domain-containing nogo receptor-interacting protein 3
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 48 Proteins, and 92% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
LOW QUALITY PROTEIN: ornithine decarboxylase antizyme 1
uncharacterized LOC120391623, transcript variant X6
uncharacterized LOC120391623, transcript variant X3
uncharacterized LOC120391623, transcript variant X2
uncharacterized LOC120391623, transcript variant X10
uncharacterized LOC120391623, transcript variant X4
uncharacterized LOC120391623, transcript variant X9
uncharacterized LOC120391623, transcript variant X7
uncharacterized LOC120391623, transcript variant X5
uncharacterized LOC120391623, transcript variant X1
uncharacterized protein LOC120391623 isoform X1
uncharacterized LOC120391623, transcript variant X8
uncharacterized protein LOC120391623 isoform X2
splicing factor 3a subunit 2, transcript variant X2
splicing factor 3a subunit 2, transcript variant X1
splicing factor 3a subunit 2, transcript variant X3
splicing factor 3a subunit 2, transcript variant X4
pleckstrin homology domain containing J1
pleckstrin homology domain-containing family J member 1
DOT1 like histone lysine methyltransferase, transcript variant X4
DOT1 like histone lysine methyltransferase, transcript variant X5
DOT1 like histone lysine methyltransferase, transcript variant X2
DOT1 like histone lysine methyltransferase, transcript variant X1
DOT1 like histone lysine methyltransferase, transcript variant X3
DOT1 like histone lysine methyltransferase, transcript variant X7
DOT1 like histone lysine methyltransferase, transcript variant X6
histone-lysine N-methyltransferase, H3 lysine-79 specific isoform X7
histone-lysine N-methyltransferase, H3 lysine-79 specific isoform X2
histone-lysine N-methyltransferase, H3 lysine-79 specific isoform X4
histone-lysine N-methyltransferase, H3 lysine-79 specific isoform X5
histone-lysine N-methyltransferase, H3 lysine-79 specific isoform X1
histone-lysine N-methyltransferase, H3 lysine-79 specific isoform X3
histone-lysine N-methyltransferase, H3 lysine-79 specific isoform X6
uncharacterized LOC120391642, transcript variant X3
uncharacterized LOC120391642, transcript variant X2
uncharacterized LOC120391642, transcript variant X1
adaptor related protein complex 3 subunit delta 1, transcript variant X1
adaptor related protein complex 3 subunit delta 1, transcript variant X2
MOB kinase activator 3A, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 42 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
MOB kinase activator 3A, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 42 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
MAPK interacting serine/threonine kinase 2
MAP kinase-interacting serine/threonine-protein kinase 2
uncharacterized LOC120391786, transcript variant X2
uncharacterized LOC120391786, transcript variant X1
BTB domain containing 2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
BTB domain containing 2, transcript variant X5
BTB domain containing 2, transcript variant X2
BTB domain containing 2, transcript variant X1
BTB/POZ domain-containing protein 2 isoform X1
BTB domain containing 2, transcript variant X3
BTB/POZ domain-containing protein 2 isoform X2
BTB/POZ domain-containing protein 2 isoform X3
casein kinase 1 gamma 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 40 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
casein kinase 1 gamma 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 74 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
casein kinase 1 gamma 2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 40 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
casein kinase 1 gamma 2, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 78 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
casein kinase 1 gamma 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 40 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
secretory carrier membrane protein 4, transcript variant X2
secretory carrier membrane protein 4, transcript variant X3
secretory carrier membrane protein 4, transcript variant X1
secretory carrier-associated membrane protein 4 isoform X1
secretory carrier-associated membrane protein 4 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 57 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized LOC120391877, transcript variant X1
uncharacterized LOC120391877, transcript variant X2
AN1-type zinc finger protein 6-like, transcript variant X1
AN1-type zinc finger protein 6-like, transcript variant X2
AN1-type zinc finger protein 6-like isoform X1
AN1-type zinc finger protein 6-like isoform X2
abhydrolase domain containing 17A, depalmitoylase, transcript variant X3
alpha/beta hydrolase domain-containing protein 17A isoform X2
abhydrolase domain containing 17A, depalmitoylase, transcript variant X2
abhydrolase domain containing 17A, depalmitoylase, transcript variant X1
alpha/beta hydrolase domain-containing protein 17A isoform X1
diencephalon/mesencephalon homeobox protein 1-like, transcript variant X1
diencephalon/mesencephalon homeobox protein 1-like, transcript variant X2
diencephalon/mesencephalon homeobox protein 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 59% coverage of the annotated genomic feature by RNAseq alignments
transcription factor 3, transcript variant X6
transcription factor 3, transcript variant X7
transcription factor 3, transcript variant X3
transcription factor 3, transcript variant X5
transcription factor 3, transcript variant X11
transcription factor 3, transcript variant X12
transcription factor 3, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
transcription factor 3, transcript variant X2
transcription factor 3, transcript variant X1
transcription factor 3, transcript variant X10
transcription factor 3, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
transcription factor 3, transcript variant X8
transcription factor E2-alpha isoform X1
transcription factor E2-alpha isoform X3
transcription factor E2-alpha isoform X5
transcription factor E2-alpha isoform X4
transcription factor E2-alpha isoform X6
transcription factor E2-alpha isoform X7
transcription factor E2-alpha isoform X2
transcription factor E2-alpha isoform X8
transcription factor E2-alpha isoform X10
transcription factor E2-alpha isoform X11
transcription factor E2-alpha isoform X12
transcription factor E2-alpha isoform X9
transcription factor 3, transcript variant X13
transcription factor E2-alpha isoform X13
transcription factor 3, transcript variant X14
transcription factor E2-alpha isoform X14
uncharacterized LOC120391566, transcript variant X2
uncharacterized LOC120391566, transcript variant X1
uncharacterized LOC120391567, transcript variant X1
uncharacterized LOC120391567, transcript variant X2
uncharacterized LOC120391567, transcript variant X3
uncharacterized protein LOC120391566 isoform X1
uncharacterized protein LOC120391566 isoform X2
methyl-CpG binding domain protein 3, transcript variant X3
methyl-CpG-binding domain protein 3 isoform X3
methyl-CpG binding domain protein 3, transcript variant X1
methyl-CpG binding domain protein 3, transcript variant X4
methyl-CpG-binding domain protein 3 isoform X1
methyl-CpG-binding domain protein 3 isoform X4
methyl-CpG binding domain protein 3, transcript variant X2
methyl-CpG-binding domain protein 3 isoform X2
mex-3 RNA binding family member D, transcript variant X2
mex-3 RNA binding family member D, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
unconventional myosin-Vb-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 46 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
unconventional myosin-Vb-like, transcript variant X2
unconventional myosin-Vb-like isoform X1
unconventional myosin-Vb-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
nuclear factor I C, transcript variant X1
nuclear factor I C, transcript variant X2
small integral membrane protein 24, transcript variant X2
small integral membrane protein 24, transcript variant X1
small integral membrane protein 24 isoform X2
small integral membrane protein 24 isoform X1
deoxyhypusine hydroxylase, transcript variant X5
deoxyhypusine hydroxylase, transcript variant X1
deoxyhypusine hydroxylase, transcript variant X3
deoxyhypusine hydroxylase, transcript variant X4
deoxyhypusine hydroxylase, transcript variant X2
protein ANTAGONIST OF LIKE HETEROCHROMATIN PROTEIN 1-like
fizzy and cell division cycle 20 related 1, transcript variant X1
fizzy and cell division cycle 20 related 1, transcript variant X3
fizzy and cell division cycle 20 related 1, transcript variant X4
fizzy and cell division cycle 20 related 1, transcript variant X2
fizzy and cell division cycle 20 related 1, transcript variant X5
uncharacterized protein C19orf71 homolog
GRAM domain-containing protein 2A-like, transcript variant X1
GRAM domain-containing protein 2A-like, transcript variant X2
GRAM domain-containing protein 2A-like, transcript variant X4
GRAM domain-containing protein 2A-like, transcript variant X5
GRAM domain-containing protein 2A-like, transcript variant X3
GRAM domain-containing protein 2A-like isoform X2
GRAM domain-containing protein 2A-like isoform X1
GRAM domain-containing protein 2B-like isoform X4
GRAM domain-containing protein 2A-like isoform X3
major facilitator superfamily domain containing 12
major facilitator superfamily domain-containing protein 12
high mobility group 20B, transcript variant X1
high mobility group 20B, transcript variant X2
high mobility group 20B, transcript variant X3
SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily E member 1-related
GIPC PDZ domain containing family member 3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 74% coverage of the annotated genomic feature by RNAseq alignments
thromboxane A2 receptor, transcript variant X2
thromboxane A2 receptor, transcript variant X1
thromboxane A2 receptor, transcript variant X3
phosphatidylinositol-4-phosphate 5-kinase type 1 gamma, transcript variant X3
phosphatidylinositol-4-phosphate 5-kinase type 1 gamma, transcript variant X2
phosphatidylinositol-4-phosphate 5-kinase type 1 gamma, transcript variant X1
phosphatidylinositol-4-phosphate 5-kinase type 1 gamma, transcript variant X5
phosphatidylinositol-4-phosphate 5-kinase type 1 gamma, transcript variant X4
phosphatidylinositol 4-phosphate 5-kinase type-1 gamma isoform X5
phosphatidylinositol 4-phosphate 5-kinase type-1 gamma isoform X4
phosphatidylinositol 4-phosphate 5-kinase type-1 gamma isoform X2
phosphatidylinositol 4-phosphate 5-kinase type-1 gamma isoform X3
phosphatidylinositol 4-phosphate 5-kinase type-1 gamma isoform X1
tight junction protein 3, transcript variant X2
tight junction protein 3, transcript variant X4
tight junction protein 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 37 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
tight junction protein 3, transcript variant X3
amyloid beta precursor protein binding family A member 3
amyloid-beta A4 precursor protein-binding family A member 3
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 91% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: 39S ribosomal protein L54, mitochondrial
mucosa-associated lymphoid tissue lymphoma translocation protein 1-like, transcript variant X2
mucosa-associated lymphoid tissue lymphoma translocation protein 1-like, transcript variant X1
mucosa-associated lymphoid tissue lymphoma translocation protein 1-like
retina and anterior neural fold homeobox 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
retina and anterior neural fold homeobox protein 2
megakaryocyte-associated tyrosine kinase, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 32 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
megakaryocyte-associated tyrosine kinase, transcript variant X3
megakaryocyte-associated tyrosine kinase, transcript variant X2
megakaryocyte-associated tyrosine-protein kinase isoform X2
megakaryocyte-associated tyrosine-protein kinase isoform X1
zinc finger RNA binding protein 2, transcript variant X3
zinc finger RNA binding protein 2, transcript variant X1
zinc finger RNA binding protein 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
zinc finger RNA-binding protein 2 isoform X3
zinc finger RNA-binding protein 2 isoform X1
zinc finger RNA-binding protein 2 isoform X2
zinc finger RNA binding protein 2, transcript variant X4
zinc finger RNA-binding protein 2 isoform X4
ELAV like RNA binding protein 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 65 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
ELAV like RNA binding protein 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 65 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
ELAV like RNA binding protein 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 65 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
ELAV like RNA binding protein 1, transcript variant X1
excitatory amino acid transporter 5-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 37 Proteins, and 63% coverage of the annotated genomic feature by RNAseq alignments
PML-RARA regulated adaptor molecule 1, transcript variant X2
PML-RARA-regulated adapter molecule 1 isoform X2
PML-RARA regulated adaptor molecule 1, transcript variant X1
PML-RARA-regulated adapter molecule 1 isoform X1
DNA polymerase epsilon 4, accessory subunit
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 93% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 77% coverage of the annotated genomic feature by RNAseq alignments
potassium voltage-gated channel subfamily V member 2-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
NADH:ubiquinone oxidoreductase subunit A7
NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 7
KN motif and ankyrin repeat domains 3, transcript variant X2
KN motif and ankyrin repeat domain-containing protein 3 isoform X2
KN motif and ankyrin repeat domains 3, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
KN motif and ankyrin repeat domains 3, transcript variant X1
KN motif and ankyrin repeat domains 3, transcript variant X4
KN motif and ankyrin repeat domain-containing protein 3 isoform X3
KN motif and ankyrin repeat domain-containing protein 3 isoform X1
KN motif and ankyrin repeat domain-containing protein 3 isoform X4
uncharacterized LOC120391886, transcript variant X2
uncharacterized LOC120391886, transcript variant X1
RAB11B, member RAS oncogene family, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 119 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
RAB11B, member RAS oncogene family, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 119 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
RAB11B, member RAS oncogene family, transcript variant X2
membrane associated ring-CH-type finger 2, transcript variant X1
membrane associated ring-CH-type finger 2, transcript variant X2
membrane associated ring-CH-type finger 2, transcript variant X3
uncharacterized LOC120391840, transcript variant X2
uncharacterized LOC120391840, transcript variant X1
heterogeneous nuclear ribonucleoprotein M, transcript variant X1
heterogeneous nuclear ribonucleoprotein M isoform X1
heterogeneous nuclear ribonucleoprotein M, transcript variant X2
heterogeneous nuclear ribonucleoprotein M isoform X2
translocase of inner mitochondrial membrane 44
mitochondrial import inner membrane translocase subunit TIM44
maestro heat-like repeat-containing protein family member 2B
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 87% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC120391519, transcript variant X2
uncharacterized LOC120391519, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 90% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC120391803, transcript variant X2
uncharacterized LOC120391803, transcript variant X1
uncharacterized protein LOC120391802 isoform X2
ceramide synthase 2-like, transcript variant X1
ceramide synthase 2-like, transcript variant X2
ceramide synthase 2-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 97% coverage of the annotated genomic feature by RNAseq alignments
LSM7 homolog, U6 small nuclear RNA and mRNA degradation associated
U6 snRNA-associated Sm-like protein LSm7
signal peptide peptidase like 2B, transcript variant X4
signal peptide peptidase like 2B, transcript variant X1
signal peptide peptidase like 2B, transcript variant X2
signal peptide peptidase like 2B, transcript variant X6
signal peptide peptidase like 2B, transcript variant X5
signal peptide peptidase like 2B, transcript variant X3
signal peptide peptidase-like 2B isoform X1
signal peptide peptidase-like 2B isoform X2
signal peptide peptidase-like 2B isoform X5
signal peptide peptidase-like 2B isoform X4
signal peptide peptidase-like 2B isoform X3
transmembrane serine protease 9, transcript variant X2
transmembrane serine protease 9, transcript variant X1
translocase of inner mitochondrial membrane 13
mitochondrial import inner membrane translocase subunit Tim13
NADH:ubiquinone oxidoreductase subunit A11, transcript variant X2
NADH:ubiquinone oxidoreductase subunit A11, transcript variant X1
NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 11
vimentin type intermediate filament associated coiled-coil protein
vimentin-type intermediate filament-associated coiled-coil protein
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 53% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 40% coverage of the annotated genomic feature by RNAseq alignments
RAN binding protein 3, transcript variant X2
RAN binding protein 3, transcript variant X1
RAN binding protein 3, transcript variant X3
COORDINATES: nucleotide motif:Rfam:12.0:RF00548
excitatory amino acid transporter 1-like, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 88 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
excitatory amino acid transporter 1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 88 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
excitatory amino acid transporter 1-like, transcript variant X4
excitatory amino acid transporter 1-like, transcript variant X3
excitatory amino acid transporter 1-like, transcript variant X5
excitatory amino acid transporter 1-like, transcript variant X6
excitatory amino acid transporter 1-like, transcript variant X1
excitatory amino acid transporter 1-like isoform X1
excitatory amino acid transporter 1-like isoform X2
excitatory amino acid transporter 1-like isoform X3
lon peptidase 1, mitochondrial, transcript variant X1
lon protease homolog, mitochondrial isoform X1
lon peptidase 1, mitochondrial, transcript variant X2
lon protease homolog, mitochondrial isoform X2
ribosomal protein L36, transcript variant X1
ribosomal protein L36, transcript variant X2
ribosomal protein L36, transcript variant X3
ribosomal protein L36, transcript variant X4
uncharacterized LOC120391772, transcript variant X1
uncharacterized LOC120391772, transcript variant X2
uncharacterized LOC120391539, transcript variant X2
uncharacterized LOC120391539, transcript variant X1
transfer RNA glutamine (anticodon CUG); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA serine (anticodon AGA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
maestro heat-like repeat family member 5